The anterior cruciate ligament (ACL) of the knee is vital for proper joint function and is commonly ruptured during sports injuries or car accidents. Due to a lack of intrinsic healing capacity and drawbacks with allografts and autografts, there is a need for a tissue engineered ACL replacement. Our group has previously used aligned sheets of electrospun polycaprolactone nanofibers to develop solid cylindrical bundles of longitudinally aligned nanofibers. We have shown that these nanofiber bundles support cell proliferation and elongation and the hierarchical structure and material properties are similar to the native human ACL. It is possible to combine multiple nanofiber bundles to create a scaffold that attempts to mimic the macro-scale structure of the ACL. The goal of this work was to develop a hierarchical bioactive scaffold for ligament tissue engineering using connective tissue growth factor (CTGF) conjugated nanofiber bundles and evaluate the behavior of mesenchymal stem cells (MSCs) on these scaffolds in vitro and in vivo. CTGF was immobilized onto the surface of individual nanofiber bundles or scaffolds consisting of multiple nanofiber bundles. The conjugation efficiency and the release of conjugated CTGF was assessed using X-ray photoelectron spectroscopy, assays, and immunofluorescence staining. Scaffolds were seeded with MSCs and maintained in vitro for 7 days (individual nanofiber bundles), in vitro for 21 days (scaled-up scaffolds of 20 nanofiber bundles) or in vivo for 6 weeks (small scaffolds of 4 nanofiber bundles) and ligament specific tissue formation was assessed in comparison to non-CTGF conjugated control scaffolds. Results showed that CTGF conjugation encouraged cell proliferation and ligament specific tissue formation in vitro and in vivo. The results suggest that hierarchical electrospun nanofiber bundles conjugated with CTGF are a scalable and bioactive scaffold for ACL tissue engineering.
Introduction
The anterior cruciate ligament (ACL) is located in the knee and runs from the lateral posterior aspect of the femoral condyle to the medial anterior aspect of the tibial plateau 1 . The ACL is vital for joint stability and it functions primarily as a restraint to excessive translations of the tibia relative to the femur 2, 3 . The ACL is primarily composed of collagen fibers arranged in a unique hierarchical structure and a lack of vascularization means that the ligament has a low intrinsic healing capacity 4, 5 . It is estimated that up to 200,000 ACL injuries occur in the United States annually and the monetary burden of these injures and subsequent treatment is estimated to be $1 billion each year 6, 7 . Untreated tears of the ACL can cause knee pain, bone bruising, excessive joint laxity, and damage to the surrounding cartilage and menisci of the knee. Following an ACL injury, surgical replacement of the ACL with an autograft or allograft is typically attempted to restore function and stability to the injured knee. However drawbacks exist to both intervention techniques. Although allografts have been historically successful, morbidity at the site of tissue donation can result in pain, tendonitis and weakness 8, 9 . Allograft tissue obtained from cadavers can also be used to replace the ACL however tissue supply is limited and disease transmission can be problematic 10 . Thus there is interest in developing a tissue engineered replacement ACL that can overcome the limitations of traditional allografts and autografts.
The field of tissue engineering aims to combine scaffolds, cells, and signaling molecules to create a replacement for damaged biological tissue. Electrospinning is a versatile scaffold fabrication technique which uses biodegradable polymers to create a nanoscale structure that mimics the structure of the extracellular matrix 11, 12 . Braided electrospun scaffolds have been shown to encourage cell proliferation and upregulation of tenogenic markers 13, 14 whereas laminated electrospun sheets have successfully encouraged cell infiltration 15 . However, both of these approaches have demonstrated inferior mechanical properties [12] [13] [14] . A tissue engineered ACL that matches the hierarchical structure of the native ligament, has sufficient mechanical properties, and encourages the production of ligamentous tissue deposition in vitro and in vivo will likely improve the clinical treatment of ACL injury.
Our group has previously developed a technique for modifying flat sheets of aligned electrospun polycaprolactone (PCL) nanofibers to create a more robust structure 16 . These cylindrical "nanofiber bundles" are approximately 500 µm in diameter and are composed of nanofibers aligned along the longitudinal axis that mimic the native ACL structure. Nanofiber bundles are able to support short term cell growth and elongated cell morphology and have material properties that are comparable to that of the native human ACL [16] [17] [18] . The smallest functional units of the ACL are collagen fibrils that range in size from 50-500 nm and are primarily oriented parallel to the longitudinal axis 19, 20 . The individual PCL nanofibers that compose the electrospun sheets used in this study mimic this size scale 16 . Collagen fibrils of the ACL are organized into fibers and numerous collagen fibers are grouped into fascicles, approximately 100-500 µm in size. The size of these collagen fascicles is similar to the size of one nanofiber bundles. In the native ACL, multiple collagen fascicles are grouped together to form the entire ligament. Thus, in an effort to mimic the hierarchical ACL structure, multiple nanofiber bundles were combined together to form a 3D scaffold for this study.
Growth factors are chemical signaling molecules that can be used to direct cell behavior. In the context of ligament tissue engineering it would be beneficial to utilize a growth factor that encourages cell proliferation as well as the deposition of extracellular matrix material characteristic of native ligaments 21 .
Connective tissue growth factor (CTGF) is a 36-38 kDa heparin-binding protein characterized by multiple conserved cysteine-rich domains 22 . CTGF is involved in a variety of physiological processes including angiogenesis, embryo development, and would healing 23 . CTGF has been previously shown to encourage fibroblastic differentiation of stem cells, as evidenced by cell proliferation, gene expression changes, and increased matrix deposition 22, 24 . The most common way to expose cells to growth factors is by introducing the growth factor to the cells in vitro in the cell growth media. The major drawback to this technique is that growth factors have a relatively short half-life in cell growth media and are rapidly inactivated, thus making it necessary to introduce fresh growth factor during each media change 25 .
Additionally, sustained growth factor delivery in an in vivo setti ng is a challenge that needs to be addressed to facilitate the development of functionalized scaffolds. One strategy to address these challenges is to conjugate growth factors to the scaffold surface using a covalent chemical conjugation procedure 26 . This surface modification-technique utilizes chemical bonds to immobilize the growth factors to exposed functional groups on a scaffold. Chemical conjugation of growth factors to a scaffold creates functionalized nanofiber scaffolds with tunable growth factor release and a prolonged influence on cell behavior 25, 26 . Previously, electrospun scaffolds with chemically conjugated growth factors have been used to encourage neuronal differentiation, enhance wound healing, and stimulate osteogenic cellular activity [27] [28] [29] .
Previously, we have shown that individual PCL nanofiber bundles support short term in vitro cell growth and proliferation 16 , hence, this study is aimed at assessing long term cell behavior on a 3D
scaffold with multiple nanofiber bundles and chemically conjugated CTGF, both in vitro and in vivo. It is hypothesized that the combination of the unique hierarchical structure and the presence of CTGF will induce the deposition of tissue that is characteristic of ligaments, primarily collagen type I and type III.
Methods

Scaffold fabrication
Flat sheets of aligned nanofibers were fabricated using an electrospinning technique as detailed previously 16 . A 10% w/v solution of polycaprolactone (PCL, M w = 80,000, Sigma 440744, St. Louis, MO) was prepared in a 3:1 v/v mixture of chloroform and methanol. The electrospinning solution was ejected horizontally from a glass syringe outfitted with an 18-gauge blunt tipped needle at a rate of 2 mL/hr for 15 min. To create sheets of aligned nanofibers ( Figure 1A ), the collector surface was a rotating aluminum drum located 10 cm from the needle tip and rotating with a linear velocity of approximately 12 m/s. These sheets were further used to create cylindrical bundles of nanofibers ( Figure 1B ) by excising a rectangular portion of the sheet (approximately 5 cm x 175 cm) and rolling it up tightly into a cylinder 16 . This resulted in nanofiber bundles that were approximately 0.5 mm in diameter and 175 mm length, with nanofibers aligned along the longitudinal axis. For further studies nanofiber bundles were cut to 20 mm in length.
Growth factor conjugation
CTGF (Sigma SRP4702, St. Louis, MO) was covalently bound to nanofiber bundles (n=3) using a multi-step chemical conjugation technique (Figure 2A This provided a cumulative measure of the percentage of conjugated CTGF that was released from the nanofiber bundles. Porcine bone marrow-derived mesenchymal stem cells (PBMSCs) for the in vivo experiments were isolated and expanded as previously described 30 . Briefly, mononuclear cells were isolated from the femora of 4 month old pigs as described above and seeded at a density of 5,000 cells/cm 2 in 75 cm 2 flasks. PBMSCs were maintained in cell growth media consisting of high glucose Dulbecco's modified
Eagle's medium GlutaMAX, 10% FBS, 1% penicillin/streptomycin and 2.5 μg/mL amphotericin B and were expanded until passage 2. Passage 2 PBMSCs were used for the in vivo experiments.
Short-term in vitro cell culture
To assess the short-term effects of the conjugated CTGF on nanofiber bundles, OMBSCs were seeded on individual nanofiber bundles (n = 6, Figure 1B ) both with and without conjugated CTGF. After CTGF conjugation samples were sterilized using 70% ethanol and exposure to ultra-violet light.
OBMSCs at passage 4 were seeded on nanofiber bundles at a concentration of approximately 200 cells/µL. Nanofiber bundles seeded with OBMSCs were maintained at 37º C and 5% CO 2 for 1 week and the cell growth media was changed every 2-3 days. Cell viability (n=6) was measured after 1, 4, and 7, days of culture using a CellTiter-Blue Cell Viability Assay (Promega G808A, Madison, WI) according to the manufacturer's instructions.
After 7 days in culture, cell adhesion was assessed by staining the cells on nanofiber bundles (n=3) with 5-Chloromethylfluorescein Diacetate (CMFDA, Life Technologies C2925, Carlsbad, CA), rhodamine-phalloidin (Cytoskeleton, Inc, Denver, CO) and 4',6-diamidino-2-phenylindole (DAPI, Life
Technologies D1306, Carlbad, CA). The cytoplasm of live cells was stained green with CMFDA followed by fixation in 3.7% formaldehyde for 50 min and permeabilization with 1% Triton-X 100 for 3 min. After permeabilization rhodamine-phalloidin was used to stain the actin cytoskeleton of cells red and DAPI was used to stain the cell nuclei blue. Nanofiber bundles were imaged with a Zeiss Axioplan 2 fluorescence microscope. Additionally, scanning electron microscopy (SEM) was used to assess the morphology and spatial organization of cells on nanofiber bundles (n=3) as previously described 16 .
Briefly, cells were fixed for imaging in a solution of 3% glutaraldehyde, 0.1 M sodium cacodylate, and 0.1 M sucrose for 45 min, then serially dehydrated and stored in a desiccator until imaged with an SEM (JSM-6500F, JOEL, Peabody, MA) operating at 10kV.
Long-term in vitro cell culture
A scaled-up scaffold (n = 12) composed of multiple nanofiber bundles was used to assess the long-term influence of conjugated CTGF on cells grown in vitro. This scaled-up scaffold was ~3 mm in diameter and consisted of ~20 nanofiber bundles cut to 20mm in length tied together at the ends with suture wire ( Figure 1C ). After fabrication scaffolds were either conjugated with CTGF (as previously described) or left unconjugated to serve as a control. OBMSCs at passage 4 were seeded on scaffolds at a concentration of approximately 600 cells/µL. Scaffolds were maintained in standard cell culture conditions for 21 days. Cell viability of scaffolds (n=12) was measured at days 1, 7, 14, and 21 using a
CellTiter-Blue viability assay.
At the end of the 21 day culture period scaffolds were assessed using histological and immunohistochemical staining and biochemical assays. To assess the biochemical content scaffolds (n=8)
were cut in half and rinsed in PBS and immediately frozen at -80 ºC. After thawing, scaffolds were digested with papain (125 ug/mL) in 0.1 M sodium acetate, 5 mM L-cysteine-HCL, and 0.05 M ethylenediaminetetraacetic acid (EDTA) under constant rotation for 18 hr. Immediately after the papain digestion DNA content was analyzed using a PicoGreen DNA assay (Thermo Fisher Scientific P11496, Waltham, MA) . Total collagen content was determined by measuring the hydroxyproline content, after acidic hydrolysis of samples (110º C for 18 hr) in concentrated hydrochloric acid (38%) 31 . Samples were assayed using a chloramine-T assay assuming a hydroxyproline-to-collagen ratio of 1:7.69 32 . The amount of sulphated glycosaminoglycans (sGAG) was quantified using a dimethylmethylene blue dye-binding (DMMB) assay as previously reported 31 .
Additional halves of scaffolds (n=8) were used for histology and immunohistochemistry.
Scaffolds were fixed for 24 hr in 10% formalin, infiltrated with a graded series of sucrose solutions, embedded in optimum cutting temperature medium (Tissue-Tek, Sakura Finetek, Torrance, CA), and flash frozen in liquid nitrogen. Embedded scaffolds were cryosectioned axially through the center to obtain 10 µm slices which were fixed to microscope slides. Sections were stained with picrosirius red to assess collagen deposition, 1% alizarin red to assess calcium accumulation, and hematoxylin and safraninO/fast green to assess sulfated glycosaminoglycan content. Kit, Vector Laboratories, UK ). Reaction was stopped when color was visible and sections were washed, dehydrated through an alcohol gradient and mounted using Vectashield (Vector Laboratories, UK).
In vivo subcutaneous implantation
A smaller scaffold (n = 8) consisting of 4 nanofiber bundles secured together at one end was implanted subcutaneously into the back of a nude mouse ( Figure 1D ). The size of the scaffold was adjusted so that it could be used with the nude mouse. CTGF was conjugated to the small scaffold surface as described above and control scaffolds were also included with no growth factors. PBMSCs at passage 2 were seeded on small scaffolds at a concentration of approximately 2000 cells/µL
All animal experiments were approved by the Ethics Committee of Trinity College Dublin (Republic of Ireland) and the Irish Medicines Board (IMB, Republic of Ireland). Control and CTGF conjugated small scaffolds (n=8 per group) were implanted into the subcutaneous space of Balb/C nude mice (Harlan, UK) using a previously described surgical procedure 33 Briefly, 2 subcutaneous pockets were created on both flanks of the mice under aseptic conditions through an incision made on the dorsal side of the mouse. Then, one small scaffold was implanted in each subcutaneous pocket (2 small scaffolds per animal). All small scaffolds were harvested at 6 weeks of in vivo implantation. Small scaffolds were analyzed for gross appearance and collagenous tissue formation by picrosirius red histology and immunohistochemistry, as described above.
Statistics
Data is presented as mean ± standard error of the mean. Data analysis was performed using Minitab (Minitab, Inc., State College, PA). For all quantitative measures, comparisons were performed using a two-way analysis of variance (ANOVA) with Tukey's post-hoc test. Differences corresponding to a p-value of less than 0.05 were considered to be statistically significant.
Results
Growth factor conjugation
The covalent chemical conjugation of CTGF to electrospun nanofibers was verified using XPS analysis after modification of the nanofiber bundles with the linker molecules and CTGF. Initially since unmodified PCL consists only of carbon and oxygen atoms there is no nitrogen present. After modifying with polyallylamine to add amines groups on the surface of the nanofiber bundles, the surface elemental nitrogen composition was 1.5%. The addition of maleimides terminals using N-succinimidyl-3-maleimidoproprionate resulted in a 0.8% increase in the nitrogen composition of the surface. Finally after adding the growth factor CTGF, which consists of multiple conserved cysteine rich domains, the final nitrogen composition was 3.5%. The increase in nitrogen could be seen visually by inspecting the nitrogen peak of the XPS survey before and after CTGF conjugation ( Figure 2B ). This increase in elemental nitrogen percentage after each subsequent modification step indicates successful conjugation.
Immunofluorescence labeling demonstrated that the conjugated CTGF was distributed uniformly across the surface of nanofiber bundles, as intended ( Figure 2C ). A CTGF ELISA was used to determine how much CTGF did not conjugate on to the nanofiber surfaces, as a quantitative measure of conjugation efficiency. During the conjugation procedure each sample was exposed to 10 ng of CTGF in dH 2 O. After the 2 hr incubation period, an average of only 0.466 (± 0.028) ng of CTGF remained in the dH 2 O ( Figure   2D ). This demonstrates that 95% of the CTGF was successfully conjugated to the nanofiber bundles. The same ELISA was also used to assess how much of CTGF was released from nanofiber bundles over a 2 week time period. The results showed that over the 2 week time period less the 6% of conjugated CTGF was released from the samples ( Figure 2E ). In the first 5 days there was a slight burst release where ~ 5%
of CTGF was released however, in the following 9 days only an additional 1% of the CTGF was released
Short-term in vitro cell culture
The CellTiter-Blue metabolic assay revealed that cells attached and remained viable on individual nanofiber bundles both with and without conjugated CTGF for up to 7 days in culture ( Figure 3A ). There were no differences in metabolic activity level of the cells on nanofiber bundles with or without CTGF, and the metabolic activity level of cells on all nanofiber bundles remained relatively constant over time.
SEM images showed that cells adhered, spread, and colonized on all nanofiber bundles ( Figure 3B, 3D ).
Additionally cells appeared to have adopted an elongated morphology along the direction of the nanofibers (along the longitudinal axis of the nanofiber bundle) for all nanofiber bundles. Similarly, after 7 days of culture, fluorescence microscopy images showed elongated cells covering the surfaces of all nanofiber bundles ( Figure 3C, 3E ).
Long-term in vitro cell culture
The CellTiter-Blue assay revealed significant differences in the metabolic activity of cells on control and CTGF scaffolds consisting of ~20 nanofiber bundles. At each time point investigated the metabolic activity of cells on CTGF scaffolds was significantly higher than the metabolic activity of cells grown on control scaffolds ( Figure 4A ). Additionally the metabolic activity of cells on scaffolds Biochemical analysis revealed that by Day 21 the amount of accumulated collagen (normalized to µg of DNA) in CTGF conjugated scaffolds was significantly higher than the collagen accumulated in control scaffolds (p=0.031, Figure 4C ). The DMMB assay to determine sGAG accumulation within the scaffolds showed that by Day 21 of culture the sGAG content (normalized to µg of DNA) of CTGF scaffolds was significantly lower than the sGAG content of control scaffolds (p=0.0008, Figure 4D ).
Histology performed using a picrosirius red stain after 21 days of culture showed that there was notable collagen deposition by cells grown on CTGF scaffolds compared to control scaffolds ( Figure 5A , 5B). The collagen was deposited primarily around nanofiber bundles that were on the exterior of the scaffold, which some deposition reaching towards the interior. There was no notable deposition of glycosaminoglycans (red/pink stain) or calcium (bright red), based on safraninO/fast green and alizarin red stains respectively, on either control or CTGF scaffolds ( Figure 5C-F) . Immunohistochemical analysis showed that there was no apparent labeling of collagen on control scaffolds ( Figure 5G , 5I). The collagen deposited on the CTGF scaffolds stained positive for collagen type I and type III ( Figure 5H, 5J ).
In vivo subcutaneous implantation
CTGF conjugated scaffolds implanted in vivo showed more homogenous collagen coverage around the nanofiber bundles whereas the control in vivo small scaffolds showed uneven covering of collagen with different staining intensity in some places around the nanofiber bundles ( Figure 6A , 6B).
The collagen type I and III immunohistochemistry showed uniform staining around the CTGF conjugated nanofiber bundles indicating the even distribution of ligament specific tissue in presence of CTGF ( Figure   6D , 6F). The periphery of control nanofiber bundles stained intensely for collagen type I staining and relatively weakly for collagen type III ( Figure 6C, 6E ). This could indicate that non-specific fibrous tissue is forming on the unconjugated nanofiber bundles.
Discussion
The key requirements for a tissue engineered ligament scaffold have been well described previously 21, 34 . The scaffold must be made from a biocompatible material and closely match the structural and mechanical properties of the native tissue. The scaffolds investigated in this work represent a hierarchal construct that mimics the structure of the native human ACL using sheets of aligned nanofibers prepared using a standard electrospinning technique. By rolling rectangular sections of the electrospun nanofiber sheets to create nanofiber bundles it creates a robust structure which supports cell growth and proliferation, cell elongation, and has material properties that are comparable to the properties of the native human ACL [16] [17] [18] . Other have attempted to use stacked PCL sheets for ACL replacement and while transient immune responses were noted 15 , they subsided and the potential for heparin mediated growth factor release was noted, as a technique for further encouraging de novo extracellular matrix deposition 35, 36 . Similarly, Bosworth et al. reported that tightly wound PCL yarn could be utilized as a substrate for tendon fibroblast adhesion and proliferation 37 . Modifications to traditional PCL have also been investigated as materials for ligament scaffolds, particularly ultra-high molecular weight PCL (UHMWPCL) and PCL with the addition of L-lactic acid (PCLC) with promising results 38, 39 . In the current study, a scaffold composed of multiple nanofiber bundles was created to better mimic the hierarchal structure of the collagen in the native ACL on macro, micro, and nano size scales, and provide space for matrix deposition between and around the nanofiber bundles.
In addition to scaffold material, it is also important to consider the structure of the scaffold. The native ACL possess a complex hierarchical structure with collagen fibrils primarily oriented along the longitudinal axis of the ligament 20 , and then organized into fascicles 4 . The primarily parallel orientation is thought to lend tensile strength and stability to the ligament 5 . The scaffold presented in this work was fabricated to attempt to mimic this hierarchical structure. The electrospun PCL nanofibers which mimic the collagen fibrils are tightly rolled upon themselves to create nanofiber bundles which mimic the collagen fascicles. Previous work showed that these individual nanofiber bundles promoted cell adhesion and proliferation 16 . In order to provide a suitable ligament replacement a scaffold must also be able to withstand the repeated tensile loading experienced by native ligaments. Previous mechanical testing revealed that when pulled to failure at a physiologically relevant strain rate the modulus, yield stress, and yield stress and yield strain of nanofiber bundles mimic the material properties of the native human ACL, suggesting this scaffold has the potential to meet the mechanical demands of the ligament 16 . To better mimic the overall ACL structure multiple nanofiber bundles were grouped together by tying the ends together, which allows the nanofiber bundles to lie parallel to one another. Although the native collagen fascicles of ACL are not perfectly parallel to one another, particularly when comparing fascicles in the in the anteromedial and posterolateral bundles of the ligament, this scaffold structure represents a first step at mimicking the hierarchical ACL structure. Other groups have attempted to recreate the hierarchical ACL structure with various techniques. Two popular techniques are utilizing braided or twisted strands of material to increase stiffness and tensile strength, however encouraging cell infiltration can be challenging 13, [39] [40] [41] [42] . A recent study comparing braided electrospun PCL sheets to stacked electrospun PCL sheets showed that the braided scaffolds possessed improved tensile strength which better mimicked the native ACL, however cell infiltration and proliferation was superior in stacked constructs 43 .
In order to encourage cell adhesion and proliferation as well as the deposition of native ligament ECM by the cells, we investigated the chemical conjugation of growth factors on the surface of the scaffold. The chemical conjugation technique used in this study resulted in a 95% conjugation efficiency, which suggests a secure covalent bond between the PCL, linker molecules, and the CTGF. After an initial burst release, over a two week time period only ~6% of the conjugated CTGF was released from the scaffold. Previous studies using similar techniques to covalently immobilize growth factors on scaffold surfaces have showed similar release profiles 28, 44 . The initial burst release of CTGF into the surrounding media could be due to the release of some unconjugated CTGF that was physically trapped within the porous network of nanofibers and required multiple days to diffuse out into the surrounding solution. The CTGF that remains covalently conjugated to the nanofiber bundles is thought to influence cells that adhere to the scaffold via juxtacrine signal transduction 45 . When cells are in contact with the conjugated growth factors, signal transduction pathways are initiated which lead to cellular adaptation and upregulation of collagen I and III production 29 .
After one week of in vitro culture there was no difference in cell metabolic activity on nanofiber bundles with and without conjugated with CTGF. Thus, for early time points the presence of the CTGF likely has no impact on cell proliferation and viability. Other groups that have utilized growth factors for ligament tissue engineering have found differences in cell proliferation as early as 7 days in vitro.
Notably, after 1 week of culture Sahoo et al. demonstrated significantly higher viability when cells were grown on knitted silk scaffolds that had been with electrospun nanofibers made of a PLGA/basic fibroblastic growth factor (bFGF) blend, compared to the same scaffolds without bFGF 46 . However this response could be due to the release profile of the bFGF, since nearly 60% was released into the surrounding media in the first 7 days 47 . Similarly, Hankemeier et al. showed that after 7 days of culture higher doses of bFGF results in a higher density of cells 48 . On our scaffolds, no apparent differences in cell coverage on nanofiber bundle surfaces were noted, and cells became elongated along the long-axis of the nanofiber bundle regardless of CTGF presence. This is somewhat surprising since previous studies have shown that the presence of CTGF induces a more elongated cell shape 22, 24 however it could be that the aligned PCL nanofibers present in our scaffold encourage cell elongation regardless of growth factor presence. The shape and morphology of cells, as dictated by the structure of the scaffold, influence cell migration and communication as well as cellular differentiation 49 . In the context of ligament tissue engineering, an elongated spindle-shaped cell morphology mimics the structure of native fibroblasts and is thought to be important for fibroblastic cellular differentiation 50, 51 .
In contrast to the cell proliferation seen on individual nanofiber bundles, when scaffolds consisting of ~20 nanofiber bundles were cultured in vitro, there were significant differences in cell proliferation in the presence of conjugated CTGF. As early as 1 day after cell seeding, DNA content and cellular metabolic activity on scaffolds with conjugated CTGF were both nearly double that of control scaffolds. This suggests that initially the cells had a greater affinity for attaching to scaffolds with conjugated CTGF. However, on individual nanofiber bundles, cells adhered at equal levels regardless of CTGF presence. This could be due to the differences in the macro-scale architecture of the scaffold.
Since the 3D scaffold consisted of multiple nanofiber bundles, each conjugated with CTGF, the larger area of exposed surface area for growth factor could encourage more cell attachment. It is difficult to compare our initial cell attachment results to those of other groups, since typically cell behavior is not , and specifically in the presence of CTGF 22, 24 .
In addition to influencing cell adhesion and proliferation, conjugated CTGF had an effect on the matrix material deposited by cells in vitro. Collagen is the predominant extracellular matrix material in ligaments and its presence is crucial for repair and regeneration of fibrous tissues 53 . Robust deposition of collagen is vital for a successful tissue engineered ligament so that as the scaffold gradually degrades, de novo tissue remains in its place. Cells on all scaffolds deposited collagen around the nanofiber bundles.
The collagen deposition was mostly observed around the outside of the scaffold where it bridged the gaps between nanofiber bundles, however some collagen deposition was also present toward the interior of the .
In order to further encourage more robust deposition of collagen around and between the individual nanofiber bundles that compose the 3D scaffold it may be necessary to incorporate mechanical stimulation. Previous groups have shown that compared to static culture, tensile loading of polymer scaffolds during culture encourages more cellular deposition of highly aligned collagen fibers similar to those observed in ligaments 56, 57 . Additionally, nano-scale alterations such as modifying the nanofibers to have a crimp-like microarchitecture may encourage ECM deposition and cell differentiation 58, 59 . On the scaffolds presented in this study, collagen deposition was notably more pronounced on scaffolds with conjugated CTGF. Quantitatively, the measured amount of accumulated collagen (normalized for DNA content) was nearly 4 times higher on CTGF scaffolds compared to control scaffolds. CTGF presence has been previously shown to stimulate the robust production of collagen in vitro in both fibroblasts and mesenchymal stem cells based on assessment of mRNA levels and histological staining of tissues 22, 23 .
Ideally, the extracellular matrix produced by cells on a tissue engineered ligament should mimic the structure and biological function of the native ligament ECM as much as possible. Thus, when considering collagen deposition on a scaffold it is important to not only note the presence of collagen, but also the specific types of collagen. Collagen type I is the major collagen found in ligaments however collagen type III is also present 4 . Type III collagen is found throughout the ACL as a component of reticular fibers, a loose connective tissue that divide type I collagen bundles. Immunohistochemistry after 3 weeks in vitro showed that on scaffolds with conjugated CTGF the collagen that was deposited on the surface of the nanofiber bundles was primarily types I and III. In contrast, on the control scaffolds there was essentially no evidence of either collagen I or III staining. There has been some evidence to suggest that the levels of different types of collagen fluctuate during tendon development, where type III collagen is deposited initially and later replaced by type I collagen 60 . Similarly during the connective tissue healing process some groups have found an initial increase in type III collagen followed by additional type I collagen deposition 61, 62 . Thus in future work it may be beneficial to quantify the types of collagen present to assess early recapitulation of the ligament development and healing process. Additionally notable deposition of collagen types I and III could suggest that the OBMSCs seeded on the scaffolds are beginning to differentiate into fibroblasts, cells characteristic of ligaments 63, 64 . In future studies, gene expression changes will be investigated to further confirm cell differentiation.
There was no apparent deposition of calcium or sGAG on any scaffolds. The absence of calcium is appropriate since no calcium is present in native ligaments. By Day 21 the amount of sGAG accumulated on CTGF scaffolds was lower than the accumulated sGAG on control scaffolds. Because high sGAG production is typically associated with chondrogenic differentiation, less accumulation of sGAG further suggests that the OBMSCs seeded on the scaffolds conjugated with CTGF may be differentiating into fibroblasts 65 . The ACL does have a small amount of sGAG, about 9% of the weight of the dry tissue, which is thought to be important for the viscoelastic mechanical behavior 4, 66 . In future studies it may be necessary to optimize the amount of CTGF present in order to regulate the spatial deposition of both sGAG and collagen.
In an effort to better understand the in vivo response of cells to the scaffold and conjugated polymer scaffold subcutaneously in an athymic rat and found thorough host cell infiltration which led to the deposition of de novo tissue within the scaffold 68, 69 . Future studies will explore implanting cell-free and cell-laden scaffolds in more challenging orthotopic locations.
Overall the results of this study have demonstrated that it is possible to utilize CTGF conjugation and novel biofabrication strategies to create a bioactive scaffold that mimics the hierarchal structure of the native ACL. During in vitro and in vivo culture the presence of CTGF encourages cell adhesion, proliferation, and robust deposition of collagen which is specific for ligament tissue. This suggests that the presence of CTGF may be influencing the seeded stem cells to differentiate into ligamentous cells.
Therefore the scaffold developed in this study, in combination with CTGF and cells, could serve as a tissue engineered ACL replacement. 
